Once that date passes, potency declines, and results may weaken, so replace the medication promptly
Barriers strongest argument is local GI exposurenot proven systemic absorption Barrier says its 500 mcg BPC-GI tablet is precision-pressed to dissolve throughout the approximately 20-foot GI tract
Injectable forms bypass the gastrointestinal tract, making them particularly valuable for individuals with malabsorption conditions such as pernicious anaemia, Crohn's disease, or following gastric surgery
Research Dosages Used in Published Studies Dosages in BPC-157 and TB-500 research vary by animal model, route, and study design, and the figures below describe what specific studies used rather than recommendations for any use
You do not need genetic testing to benefit from active forms, but for individuals who do carry these variants, it can be particularly relevant